119 related articles for article (PubMed ID: 38302078)
1. Effects of a single dose of rocuronium in patients with different body fat percentages: A randomised controlled trial.
An G; Qiu Y; Zhou Z; Ding X; Li C
Clin Exp Pharmacol Physiol; 2024 Mar; 51(3):e13836. PubMed ID: 38302078
[TBL] [Abstract][Full Text] [Related]
2. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
[TBL] [Abstract][Full Text] [Related]
3. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.
Leykin Y; Pellis T; Lucca M; Lomangino G; Marzano B; Gullo A
Anesth Analg; 2004 Oct; 99(4):1086-1089. PubMed ID: 15385355
[TBL] [Abstract][Full Text] [Related]
4. Prolonged neuromuscular block after rocuronium in postpartum patients.
Gin T; Chan MT; Chan KL; Yuen PM
Anesth Analg; 2002 Mar; 94(3):686-9; table of contents. PubMed ID: 11867398
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sugammadex doses calculated on the basis of corrected body weight and total body weight for the reversal of deep neuromuscular blockade in morbidly obese patients.
Li D; Wang Y; Zhou Y; Yin C
J Int Med Res; 2021 Jan; 49(1):300060520985679. PubMed ID: 33499679
[TBL] [Abstract][Full Text] [Related]
6. [Effects of sevoflurane and desflurane on pharmacodynamics of rocuronium in children].
Kang DX; Rao YQ; Ji B; Li J
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):429-433. PubMed ID: 28219129
[No Abstract] [Full Text] [Related]
7. Rocuronium Dosing by Ideal vs Total Body Weight in Obesity: A Prospective, Observational Non-inferiority Study.
McDowell M; Lewandowski A; Desai D; Nunez Cruz S; Glowacki N; Sulh A; Cirone M; Lomotan N; Hormese M
West J Emerg Med; 2024 Jan; 25(1):22-27. PubMed ID: 38205981
[TBL] [Abstract][Full Text] [Related]
8. Influence of gender on the onset and duration of rocuronium-induced neuromuscular block.
Adamus M; Koutna J; Gabrhelik T; Hubackova M; Janaskova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):301-5. PubMed ID: 18345268
[TBL] [Abstract][Full Text] [Related]
9. The time-course of action and recovery of rocuronium 0.3 mg x kg(-1) in infants and children during halothane anaesthesia measured with acceleromyography.
Driessen JJ; Robertson EN; Van Egmond J; Booij LH
Paediatr Anaesth; 2000; 10(5):493-7. PubMed ID: 11012952
[TBL] [Abstract][Full Text] [Related]
10. A Comparison Between the Adductor Pollicis Muscle Using TOF-Watch SX and the Abductor Digiti Minimi Muscle Using TetraGraph in Rocuronium-Induced Neuromuscular Block: A Prospective Observational Study.
Iwasaki H; Yamamoto M; Sato H; Doshu-Kajiura A; Kitajima O; Takagi S; Luthe SK; Suzuki T
Anesth Analg; 2022 Aug; 135(2):370-375. PubMed ID: 35061641
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of rocuronium in cholestatic patients with or without hepatocellular injury: normal onset time of initial dose and prolonged duration time after repeated doses.
Yang JJ; Wang YG; Zhang Z; Zhang ZJ; Liu J; Xu JG
J Pharm Pharm Sci; 2008; 11(3):15-21. PubMed ID: 18801303
[TBL] [Abstract][Full Text] [Related]
12. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
Barrio J; San Miguel G; García V; Pelegrín F
Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of rocuronium bromide in obese female patients.
Pühringer FK; Keller C; Kleinsasser A; Giesinger S; Benzer A
Eur J Anaesthesiol; 1999 Aug; 16(8):507-10. PubMed ID: 10500937
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular effects of rocuronium in children during halothane anaesthesia.
Vuksanaj D; Skjonsby B; Dunbar BS
Paediatr Anaesth; 1996; 6(4):277-81. PubMed ID: 8827743
[TBL] [Abstract][Full Text] [Related]
15. [Intubation conditions and the development of neuromuscular blockade with rocuronium in endoscopic ORL surgery].
Lüllwitz E; Zuzan O; Schultze-Florey T; Leuwer M; Piepenbrock S
Anaesthesist; 1997 Jan; 46(1):14-20. PubMed ID: 9082862
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of rocuronium dosing based on corrected or lean body weight on rapid sequence induction and neuromuscular blockade duration in obese female patients.
Sakızcı-Uyar B; Çelik S; Postacı A; Bayraktar Y; Dikmen B; Özkoçak-Turan I; Saçan O
Saudi Med J; 2016 Jan; 37(1):60-5. PubMed ID: 26739976
[TBL] [Abstract][Full Text] [Related]
17. Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study.
Czarnetzki C; Lysakowski C; Elia N; Tramèr MR
Acta Anaesthesiol Scand; 2012 Apr; 56(4):474-81. PubMed ID: 22260297
[TBL] [Abstract][Full Text] [Related]
18. Neuromuscular recovery following rocuronium bromide single dose in infants.
Rapp HJ; Altenmueller CA; Waschke C
Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
[TBL] [Abstract][Full Text] [Related]
19. Influence of the amount of skeletal muscle mass on rocuronium-induced neuromuscular block.
Doo AR; Lee JH; Lee Y; Ko S
Anaesth Crit Care Pain Med; 2022 Aug; 41(4):101086. PubMed ID: 35490864
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs.
Pedersen K; Kruhøffer LL; Lykkesfeldt J; Kousholt BS
Acta Vet Scand; 2022 Dec; 64(1):38. PubMed ID: 36522634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
